How Common Is Diclofenac-Associated Liver Injury? Analysis of 17,289 Arthritis Patients in a Long-Term Prospective Clinical Trial

医学 双氯芬酸 不利影响 内科学 中止 肝移植 肝损伤 类风湿性关节炎 肝病 外科 胃肠病学 麻醉 移植
作者
Loren Laine,Lawrence Goldkind,Sean Curtis,L. Connors,Zhang Yanqiong,Christoper P Cannon
出处
期刊:The American Journal of Gastroenterology [Lippincott Williams & Wilkins]
卷期号:104 (2): 356-362 被引量:132
标识
DOI:10.1038/ajg.2008.149
摘要

OBJECTIVES: Few data are available from prospective trials to define the hepatotoxicity of diclofenac, the most widely prescribed non-steroidal anti-inflammatory drug (NSAID) in the world. We determined the rate of laboratory and clinical adverse hepatic effects in a large double-blind trial of diclofenac. METHODS: Patients > or = 50 years with rheumatoid arthritis or osteoarthritis were randomly assigned to diclofenac (150 mg daily) or etoricoxib (60 or 90 mg daily). Patients with hepatic disease or who reported > or = 14 alcoholic drinks weekly were excluded. Patients had visits (with liver tests) every 4 months and were contacted by phone between visits and every 6 months after discontinuation until the end of the study. Causality assessment was performed for liver-related hospitalizations, Hy's cases (serious adverse events with AST or ALT >3 x upper limit of normal (ULN) and bilirubin >2 xULN), and liver failure/transplant/death. RESULTS: A total of 17,289 patients received diclofenac for a mean of 18 months. Liver end points with diclofenac were ALT/AST>3 xULN: 527(3.1%); ALT/AST >10 xULN: 86(0.5%); liver-related hospitalizations: 4(0.023%); Hy's cases: 2(0.012%); liver failure/death/transplant: 0. Aminotransferase elevations occurred primarily within the first 4-6 months of therapy, whereas liver-related hospitalizations occurred between 9 days and 21 months. CONCLUSIONS: Diclofenac is commonly associated with aminotransferase elevations, generally in the first 4-6 months of therapy. Clinical liver events requiring hospitalization are relatively rare (23/100,000 patients), but may develop early or late in therapy. The markedly increased rate of aminotransferase elevation with diclofenac may not be paralleled by a proportional marked increase in clinical liver events, although clinical events potentially also may be decreased with regular monitoring in a clinical trial setting.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
忧郁致远发布了新的文献求助10
1秒前
1秒前
我要的飞翔完成签到,获得积分10
2秒前
ZHOUYE发布了新的文献求助10
2秒前
3秒前
yyds的应助被有趣的桃采纳,获得10
6秒前
zhoup257完成签到,获得积分10
6秒前
嘻嘻哈哈发布了新的文献求助250
7秒前
Nole的应助被温柔的墨镜采纳,获得10
8秒前
8秒前
王硕发布了新的文献求助10
9秒前
明亮如花发布了新的文献求助10
9秒前
在路上完成签到,获得积分10
10秒前
小蘑菇的应助被Rina采纳,获得10
11秒前
云泪天痕的应助被Rina采纳,获得10
11秒前
jeong完成签到,获得积分10
11秒前
CodeCraft的应助被Rina采纳,获得10
11秒前
orixero的应助被Rina采纳,获得10
11秒前
大个的应助被Rina采纳,获得10
11秒前
隐形曼青的应助被Rina采纳,获得10
11秒前
今后的应助被Rina采纳,获得10
11秒前
完美世界的应助被Rina采纳,获得10
12秒前
Lucas的应助被Rina采纳,获得10
12秒前
12秒前
12秒前
13秒前
丰富语蕊完成签到,获得积分0
16秒前
思量完成签到,获得积分10
16秒前
情怀的应助被临州采纳,获得10
17秒前
老实白筠完成签到,获得积分10
18秒前
125hggj完成签到 ,获得积分10
18秒前
芳心纵火犯完成签到,获得积分10
19秒前
思量发布了新的文献求助10
19秒前
20秒前
AireenBeryl531举报石宇航的求助涉嫌违规
20秒前
20秒前
20秒前
20秒前
21秒前
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192903
求助须知:如何正确求助?哪些是违规求助? 9579346
关于积分的说明 21864636
捐赠科研通 7792529
什么是DOI,文献DOI怎么找? 3437107
关于科研通互助平台的介绍 2560653
邀请新用户注册赠送积分活动 2483937